Philippe Mineur

2.4k total citations · 1 hit paper
49 papers, 1.4k citations indexed

About

Philippe Mineur is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Philippe Mineur has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 26 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in Philippe Mineur's work include Chronic Lymphocytic Leukemia Research (27 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Philippe Mineur is often cited by papers focused on Chronic Lymphocytic Leukemia Research (27 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Philippe Mineur collaborates with scholars based in Belgium, United States and France. Philippe Mineur's co-authors include Philippe Martiat, Dominique Bron, Nathalie Meuleman, Basile Stamatopoulos, Pierre Zachée, Koen Van Eygen, Zwi Berneman, Laurence Lagneaux, Karen MacDonald and Gregor Verhoef and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Philippe Mineur

48 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

2009 463 citations Lucien Noens, Pierre Zachée et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Mineur Belgium	18	638	625	400	257	229	49	1.4k
Gareth Gerrard United Kingdom	21	984 1.5×	1.3k 2.1×	505 1.3×	399 1.6×	205 0.9×	75	2.2k
Jamshid S. Khorashad United Kingdom	24	2.1k 3.2×	2.4k 3.9×	283 0.7×	304 1.2×	254 1.1×	67	2.9k
Kendra Sweet United States	22	604 0.9×	1.1k 1.8×	617 1.5×	647 2.5×	180 0.8×	180	1.8k
Rudolf Weide Germany	19	344 0.5×	198 0.3×	108 0.3×	488 1.9×	331 1.4×	89	1.0k
Sandip Shah India	11	880 1.4×	1.1k 1.8×	138 0.3×	216 0.8×	106 0.5×	50	1.4k
Marco Bua United Kingdom	18	2.0k 3.2×	2.3k 3.7×	131 0.3×	246 1.0×	251 1.1×	32	2.6k
Christopher Arthur Australia	15	954 1.5×	1.7k 2.7×	551 1.4×	348 1.4×	160 0.7×	46	2.0k
David T Yeung Australia	22	1.3k 2.0×	1.6k 2.5×	408 1.0×	358 1.4×	231 1.0×	131	2.3k
David Marín United Kingdom	29	2.7k 4.2×	3.3k 5.3×	263 0.7×	473 1.8×	368 1.6×	114	4.0k
Maud Janvier France	20	483 0.8×	918 1.5×	500 1.3×	597 2.3×	382 1.7×	48	1.6k

Countries citing papers authored by Philippe Mineur

Since Specialization

Citations

This map shows the geographic impact of Philippe Mineur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Mineur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Mineur more than expected).

Fields of papers citing papers by Philippe Mineur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Mineur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Mineur. The network helps show where Philippe Mineur may publish in the future.

Co-authorship network of co-authors of Philippe Mineur

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Mineur. A scholar is included among the top collaborators of Philippe Mineur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Mineur. Philippe Mineur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Devos, Timothy, Yves Béguin, Lucien Noens, et al.. (2017). Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey. European Journal Of Haematology. 100(4). 361–366. 4 indexed citations

Damme, Michaël Van, Emerence Crompot, Nathalie Meuleman, et al.. (2016). Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance. Clinical Epigenetics. 8(1). 132–132. 27 indexed citations

Béguin, Yves, Barbara Dessars, Timothy Devos, et al.. (2015). Practical management of Chronic Myeloid Leukemia in Belgium. Open Repository and Bibliography (University of Liège). 6(1). 16–32. 1 indexed citations

Stamatopoulos, Basile, Michaël Van Damme, Emerence Crompot, et al.. (2015). Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia. Molecular Medicine. 21(1). 123–133. 55 indexed citations

Crompot, Emerence, Michaël Van Damme, Hugues Duvillier, et al.. (2015). Avoiding False Positive Antigen Detection by Flow Cytometry on Blood Cell Derived Microparticles: The Importance of an Appropriate Negative Control. PLoS ONE. 10(5). e0127209–e0127209. 18 indexed citations

Devos, Timothy, Pierre Zachée, Dominique Bron, et al.. (2014). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica. 70(2). 105–111. 6 indexed citations

Caers, Jo, Marie‐Christiane Vekemans, Karolien Beel, et al.. (2013). Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians. Annals of Medicine. 45(5-6). 413–422. 9 indexed citations

Delforge, Michel, A. Michiels, Alain Kentos, et al.. (2012). Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.. PubMed. 66(5). 371–5. 4 indexed citations

Stamatopoulos, Basile, Nathalie Meuleman, Cécile De Bruyn, et al.. (2010). A Molecular Score by Quantitative PCR as a New Prognostic Tool at Diagnosis for Chronic Lymphocytic Leukemia Patients. PLoS ONE. 5(9). e12780–e12780. 23 indexed citations

10.

Dierickx, Daan, Christiane Vermylen, Philippe Mineur, et al.. (2007). Rituximab therapy for immune anemia and thrombocytopenia: A Belgian registry run by the red cell subcomittee of the belgian society for hematology. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 92. 136–136. 1 indexed citations

11.

Sonet, Anne, Ivan Théate, Philippe Mineur, et al.. (2004). CLINICAL AND PATHOLOGICAL FEATURES OF 14 NON-HODGKINʼS LYMPHOMAS ASSOCIATED WITH COELIAC DISEASE. Acta Clinica Belgica. 59(3). 143–151. 3 indexed citations

12.

Ravoet, Christophe, Philippe Mineur, L Debusscher, et al.. (2002). Phase I-II study of a Farnesyl Transferase Inhibitor (FTI), SCH66336, in patients with myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (sAML).. Blood. 100(11). 7 indexed citations

13.

Knoops, L., et al.. (2002). ANGIOIMMUNOBLASTIC LYMPHADENOPATHY FOLLOWING CIPROFLOXACIN ADMINISTRATION. Acta Clinica Belgica. 57(2). 71–73. 2 indexed citations

14.

Larson, Richard A., M. A. Boogaerts, Elihu H. Estey, et al.. (2002). Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia. 16(9). 1627–1636. 168 indexed citations

15.

Neste, Eric Van Den, Jl. Michaux, André Delannoy, et al.. (2000). Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma. Leukemia. 14(6). 1136–1142. 35 indexed citations

16.

Neste, Eric Van Den, Philippe Martiat, Philippe Mineur, et al.. (1998). 2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia. Annals of Hematology. 76(1). 19–23. 20 indexed citations

17.

Bosly, André, Augustin Ferrant, Anne Sonet, et al.. (1995). 2-Chlorodeoxyadenosine in refractory non-Hodgkin's lymphoma: A phase II study on 50 patients.. Blood. 86(10). 212–212. 4 indexed citations

18.

Neste, Eric Van Den, Augustin Ferrant, André Delannoy, et al.. (1993). 2-chloro-deoxyadenosine With Or Without Daunorubicin for Relapsing Or Refractory Acute Myeloblastic-leukemia. Blood. 82(10). 1 indexed citations

19.

Bosly, André, Augustin Ferrant, André Delannoy, et al.. (1993). 2-chlorodeoxyadenosine Therapy in Non-hodgkins-lymphoma. Blood. 82(10). 2 indexed citations

20.

Filleul, Bertrand, Augustin Ferrant, André Delannoy, et al.. (1993). A Single Course of 2-chloro-deoxyadenosine (2-cda) Does Not Eradicate Leukemic-cells in Hairy-cell Leukemia (hcl) Patients Achieving Complete Remission. Blood. 82(10). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact